“Chloroquine” and Corona … a study that decides the future of “this magic medicine”
A new study, the largest of its kind, resolved the debate about the drug hydroxychloroquine, which was promoted by US President Donald Trump to treat the emerging coronavirus.
The study, published Monday, in the Journal of the American Medical Association, showed that chlorquine, which is originally used to treat malaria patients, was “not effective” with the Coronavirus.
Another study, published Thursday, in the “New England” Journal of Medicine also showed that the drug does not fight the virus, according to CNN.
Even before the reports were published, the US Food and Drug Administration and the National Institutes of Health issued warnings about Corona patients’ use of the drug, which is very stimulating.
“The study has virtually hammered the nail into the coffin of hydroxychloroquine,” said Dr. William Schaffner, an infectious disease expert and consultant for the American Centers for Disease Control and Prevention.
In the most recent study, conducted at Albany University, New York State, researchers examined 1,438 patients with coronavirus, who were admitted to 25 hospitals in the New York City area.
After statistical studies, it was found that the mortality rate for patients who took hydroxychloroquine was similar to those who did not take the drug.
The mortality rate for those taking hydroxychloroquine, as well as the antibiotic azithromycin, also appeared to be similar.
In addition, patients who took the combination of the drug increased their risk of heart attack during the study period at a rate of twice, which confirms that heart problems represent one of the known side effects of hydroxychloroquine, as well as its ineffectiveness with respect to the virus.
“The most important finding of this study is that it is very consistent with the guidance of previous specialized bodies issued in April,” said David Holtgrave, Dean of the School of Public Health at the University of Albany.
Source: Sky News Arabia